Knowledge and attitudes of health professionals regarding menopausal hormone therapies

References

• Ice GH. Biological anthropology and aging. J Cross Cult Gerontol 2005;20:87–90
   PubMedGoogle Scholar
• Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175:531–9
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause 2014;21:924–32
   PubMed Web of Science ®Google Scholar
• Blumel JE, Chedraui P, Baron G, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011;18:778–85
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Vaheri R, Timonen UA. 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: update of safety and quality-of-life findings. J Br Menopause Soc 2006;12:115–25
   PubMedGoogle Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Pinkerton JV, Constantine GD. Compounded non-FDA-approved menopausal hormone therapy prescriptions have increased: results of a pharmacy survey. Menopause 2016;23:359–67
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Hammar M, Kjellgren KI, Lindh-Astrand L, Brynhildsen J. Changes in women’s attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 2005;52:11–17
   PubMed Web of Science ®Google Scholar
• Ringa V, Fritel X, Varnoux N, Zins M, Quelen C, Bouyer J. Discontinuation of hormone therapy in the French GAZEL cohort 1990-2006. Fertil Steril 2010;94:1387–91
   PubMed Web of Science ®Google Scholar
• Huang KE, Xu L, I NN, Jaisamrarn U. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 2010;65:276–83
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Peralta S, Ferrer J, Palacios S, Cornago S, Quereda F. The dilemma of menopause and hormone replacement–a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women. Climacteric 2006;9:380–7
   PubMed Web of Science ®Google Scholar
• Stadberg E, Mattsson LA, Milsom I. Womens attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study. Maturitas 1997;27:109–16
   PubMed Web of Science ®Google Scholar
• Blumel JE, Castelo-Branco C, Riquelme R, et al. Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause 2002;9:377–80
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang X, Li X, He X, Zhao Y. Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey. Menopause 2014;21:1190–6
   PubMed Web of Science ®Google Scholar
• Sayakhot P, Teede HJ, Gibson-Helm M, Vincent A. Differences in clinician understanding and management of early menopause after breast cancer. Climacteric 2013;16:479–89
   PubMed Web of Science ®Google Scholar
• Sangi-Haghpeykar H, Poindexter AN. 3rd. Physicians’ views and practices concerning menopausal hormone therapy. Maturitas 2007;56:30–7
   PubMed Web of Science ®Google Scholar
• Power ML, Anderson BL, Schulkin J. Attitudes of obstetrician-gynecologists toward the evidence from the Women’s Health Initiative hormone therapy trials remain generally skeptical. Menopause 2009;16:500–8
   PubMed Web of Science ®Google Scholar
• European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016;31:926–37
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy. Climacteric 2016;19:313–15
   PubMed Web of Science ®Google Scholar
• Fahlen M, Fornander T, Johansson H, et al. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. Eur J Cancer 2013;49:52–9
   PubMed Web of Science ®Google Scholar
• Christianson MS, Ducie JA, Altman K, Khafagy AM, Shen W. Menopause education: needs assessment of American obstetrics and gynecology residents. Menopause 2013;20:1120–5
   PubMed Web of Science ®Google Scholar
• Buhling KJ, Von Studnitz FSG, Jantke A, Eulenburg C, Mueck AO. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women’s Health Initiative study: results of a survey. Menopause 2012;19:1088–91
   PubMed Web of Science ®Google Scholar
• Power ML, Zinberg S, Schulkin J. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy. Menopause 2006;13:434–41
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. Jama 2004;291:1701–12
   PubMed Web of Science ®Google Scholar
• Sayakhot P, Vincent A, Teede H. Breast cancer and menopause: perceptions of diagnosis, menopausal therapies and health behaviors. Climacteric 2012;15:59–67
   PubMed Web of Science ®Google Scholar
• Nilsen ST, Pedersen AT, Moen MH, et al. Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and Sweden. Maturitas 2001;39:83–90
   PubMed Web of Science ®Google Scholar
• Baron J, Holzman GB, Schulkin J. Attitudes of obstetricians and gynecologists toward hormone replacement therapy. Med Decis Making 1998;18:406–11
   PubMed Web of Science ®Google Scholar
• Kaplan B, Aschkenazi-Steinberg S, Yogev Y, Nahum R, Sulkes J, Phisher M. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause. Menopause 2002;9:354–9
   PubMed Web of Science ®Google Scholar
• Cartwright B, Robinson J, Seed PT, Fogelman I, Rymer J. Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density. J Clin Endocrinol Metab 2016;101:3497–505
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• Mohammed K, Abu Dabrh AM, Benkhadra K, et al. Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis. J Clin Endocrinol Metab 2015;100:4012–20
   PubMed Web of Science ®Google Scholar
• Buhling KJ, von Studnitz FS, Jantke A, Eulenburg C, Mueck AO. Attitude of German gynecologists towards prescribing HRT before and after the WHI study. Climacteric 2012;15:326–31
   PubMed Web of Science ®Google Scholar
• Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013;310:1353–68
   PubMed Web of Science ®Google Scholar
• Constantine GD, Archer DF, Graham S, Bernick BA, Mirkin S. Prescribing of FDA-approved and compounded hormone therapy differs by specialty. Menopause 2016;23:1075–82
   PubMed Web of Science ®Google Scholar
• Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2015;100:3975–4011
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Gass ML, Haines CJ, et al. Global consensus statement on menopausal hormone therapy. Climacteric 2013;16:203–4
   PubMed Web of Science ®Google Scholar
• The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Management of Menopause 2014; [cited 2017 23 Jan]. Available from: https://www.ranzcog.edu.au/Statements-Guidelines
   Google Scholar
• Morch LS, Lidegaard O, Keiding N, Lokkegaard E, Kjaer SK. The influence of hormone therapies on colon and rectal cancer. Eur J Epidemiol 2016;31:481–9
   PubMed Web of Science ®Google Scholar
• Pedersen AT, Iversen OE, Lokkegaard E, et al. Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists. Acta Obstet Gynecol Scand 2007;86:1490–5
   PubMed Web of Science ®Google Scholar
• Biglia N, Ujcic E, Kubatzki F, et al. Personal use of hormone therapy by postmenopausal women doctors and male doctors’ wives in Italy after the publication of WHI trial. Maturitas 2006;54:181–92
   PubMed Web of Science ®Google Scholar